ERELZI sol inj 50 mg/ml 2 ser pré 1 ml

7680661750068 CH-66175 L04AB01 07.15.0.

Active substances:

ERELZI sol inj 50 mg/ml 2 ser pré 1 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6617502
CPT
-
Packaging group
2
Unit
Fertigspritze(n)
Composition
etanerceptum 50 mg, acidum citricum, natrii citras dihydricus, natrii chloridum, saccharum, lysini hydrochloridum, natrii hydroxidum aut acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.76 mg.

Articles (1)

Erelzi 50 mg/1 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/01/2025
Patient information leaflet
Français
16/01/2025
Patient information leaflet
Italien
16/01/2025
Professional SmPC
Allemand
16/01/2025
Professional SmPC
Français
16/01/2025
Professional SmPC
Italien
16/01/2025

Detailed composition

Substance Quantity Type Category
etanerceptum
50.0 MG Substance Wirkstoff (Principe actif)
acidum citricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
saccharum
- Substance HNIDK
lysini hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum 25 per centum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.76 MG Substance HBESI

Reimbursement information

Public price
CHF 417.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2018

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
66175
Drug name
Erelzi, Injektionslösung in einer Fertigspritze
Galenic form
INJFS
ATC Code
L04AB01
Authorization status
Z
Dispensation category
B
First authorization
18/05/2018
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, juvenile idiopatische Arthritis (Polyarthritis, Oligoarthritis, Psoriasis-Arthritis, Enthesitis-assoziierte Arthritis), Psoriasis-Arthritis, Morbus Bechterew (ankylosierende Spondylitis), mittelschwere bis schwere Plaque-Psoriasis

Packaging details

Description (FR)
ERELZI sol inj 50 mg/ml 2 ser pré 1 ml
Description (DE)
ERELZI Inj Lös 50 mg/ml 2 Fertspr 1 ml
Market launch
18/05/2018
Narcotic (BTM)
No

Other packaging sizes

ERELZI sol inj 25 mg/0.5ml ser pré 0.5 ml
1 FESP
View
ERELZI sol inj 25 mg/0.5ml 2 ser pré 0.5 ml
2 FESP
View
ERELZI sol inj 25 mg/0.5ml 4 ser pré 0.5 ml
4 FESP
View
ERELZI sol inj 25 mg/0.5ml 12 ser pré 0.5 ml
12 FESP
View
ERELZI sol inj 50 mg/ml ser pré 1 ml
1 FESP
View
ERELZI sol inj 50 mg/ml 4 ser pré 1 ml
4 FESP
View
ERELZI sol inj 50 mg/ml 12 ser pré 1 ml
12 FESP
View
Buy us a coffee Explore the data